p53, bcl-2 and Retinoblastoma Proteins as Long-Term Prognostic Markers in Localized Carcinoma of the Prostate
Authors:
- 1 July 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 158 (1) , 131-137
Abstract
Purpose: The accumulation of p53 and bcl-2 gene products as well as the loss of the retinoblastoma (Rb) gene product have been associated with prostate cancer progression. We assessed wheth...Keywords
This publication has 31 references indexed in Scilit:
- Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancerHuman Pathology, 1995
- Prostate CancerEndocrinology and Metabolism Clinics of North America, 1994
- The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic TestsJournal of Urology, 1994
- Radical Prostatectomy for Impalpable Prostate Cancer: The Johns Hopkins Experience With Tumors Found on Transurethral Resection (Stages T1a and T1b) and on Needle Biopsy (Stage T1c)Journal of Urology, 1994
- 5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate CancerJournal of Urology, 1994
- Immunohistochemical Determination of P53 Protein Nuclear Accumulation in Prostatic AdenocarcinomaJournal of Urology, 1994
- Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinomaHuman Pathology, 1994
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening1993
- Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancerCancer, 1993
- Low-Grade, Latent Prostate Cancer Volume: Predictor of Clinical Cancer Incidence?JNCI: Journal of the National Cancer Institute, 1991